Drug Shortage Report for DIASTAT

Last updated on 2024-01-18 History
Report ID 193094
Drug Identification Number 02519070
Brand name DIASTAT
Common or Proper name DIASTAT
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) DIAZEPAM
Strength(s) 10MG
Dosage form(s) GEL
Route of administration RECTAL
Packaging size n/a
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-06-26
Actual start date
Estimated end date 2024-01-19
Actual end date 2024-01-17
Shortage status Resolved
Updated date 2024-01-18
Company comments delay in production
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v33 2024-01-18 English Compare
v32 2024-01-17 French Compare
v31 2024-01-17 English Compare
v30 2024-01-10 French Compare
v29 2024-01-10 English Compare
v28 2023-12-20 French Compare
v27 2023-12-20 English Compare
v26 2023-12-15 French Compare
v25 2023-12-15 English Compare
v24 2023-11-01 French Compare
v23 2023-11-01 English Compare
v22 2023-10-26 French Compare
v21 2023-10-26 English Compare
v20 2023-09-15 French Compare
v19 2023-09-15 English Compare
v18 2023-08-23 French Compare
v17 2023-08-23 English Compare
v16 2023-08-09 French Compare
v15 2023-08-09 English Compare
v14 2023-07-21 French Compare

Showing 1 to 20 of 33